ALAS2 and autosomal erythropoietic protoporphyria: Another aspect emerging from our experiments is the vast increase in ALAS2 mRNA in the patient samples compared to the healthy controls, which confirms earlier findings in peripheral blood samples of patients with EPP with different genetic backgrounds conducted by RT-PCR (Barman-Aksözen, et al., 2015).